Midway Research and Immunology Center Contributes to FDA Approval of New HSV Treatment
Midway Research and Immunology Center in Fort Pierce participated in the PRIOH-1 clinical trial supporting FDA approval of HOVILPRI® (pritelivir), a new treatment option for eligible patients with difficult-to-treat herpes simplex virus infections.